JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES药学与制药科学杂志

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES(英文缩写 J PHARM PHARM SCI),ISSN 1482-1826,eISSN 1482-1826,中文译名:药学与制药科学杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
5.500
JCR 分区
Q1
CAS 分区
B4
近一年发文量
21
本站 PubMed 收录统计

发文量统计区间:2025-09-24 至 2026-09-24,按本站收录文献的发表日期统计。

ISSN: 1482-1826 · eISSN: 1482-1826 · 缩写: J PHARM PHARM SCI ·中文: 药学与制药科学杂志

期刊介绍

选择期刊介绍栏目

期刊简介

《药学与制药科学杂志》是一本国际性同行评议期刊,聚焦药学与制药科学各分支领域。主要发表药物化学、药剂学、药理学、药物分析及临床药学等方向的研究。读者群包括药学科研人员、制药行业研发人员、临床药师及药学教育工作者。该刊注重从基础研究到应用转化的全链条成果,为药学领域提供跨学科交流平台。

研究方向

主要研究方向涵盖药物递送系统、药代动力学、药物化学、天然产物、药物分析、临床药学实践及药学教育等。论文类型包括原创研究论文、综述、短通讯和评论。尤其关注新药开发、制剂技术、药物治疗优化及药学服务相关主题。

期刊特色

研究取向兼顾基础与应用,强调方法学严谨性和临床相关性。论文通常需具备明确科学问题和充分实验验证。适合药学研究者、制药企业科学家、临床药师及研究生阅读参考。综述类文章多为邀稿或领域前沿总结。

投稿难度

投稿难度中等偏上,对研究的创新性、数据完整性和英文写作有较高要求。建议投稿前充分预实验、完善统计分析和文献覆盖,并严格遵循作者指南。因审稿标准较严,需预留修改时间,不适合仓促投稿。

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 最新收录文献

  1. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    1. Age-related risk factors for leftover drugs: a lifespan analysis in community pharmacies.

    作者:
    Toshiyuki Hirai, Shunsuke Hanaoka, Yuusuke Terakado, Toshiichi Seki, Hiroyuki Hayashi, Fumiyuki Watanabe
    日期:
    2026-01-01

    Medication adherence is a critical global challenge because suboptimal adherence reduces therapeutic efficacy and increases healthcare costs. While leftover drugs are vital indicators of potential adh…

  2. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    2. Integration of microphysiological systems with computational and digital twin modeling for pharmaceutical development: a systematic review.

    作者:
    Marzieh Soheili, Behdad Gilzad Kohan, Leila Rastegar, Yousef Moradi, Hamed Gilzad Kohan
    日期:
    2026-01-01

    The pharmaceutical industry faces a productivity crisis, with only ∼10% of candidates reaching approval and development costs exceeding $1-2 billion per drug. Traditional preclinical models, particula…

  3. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    3. Fenofibrate in ophthalmology: therapeutic efficacy and mechanisms.

    作者:
    Sean Chung-Hei Ho, Isabelle Xin Yu Lee, Chang Liu, Mingyi Yu, Hong Chang Tan, Gavin Siew Wei Tan, Yu-Chi Liu
    日期:
    2026-01-01

    Ophthalmic diseases are a growing global cause of visual impairment, driven by population aging and the rising prevalence of diabetes mellitus. Fenofibrate, a peroxisome proliferator-activated recepto…

  4. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    4. {"_":"Innovative hyaluronic acid-decorated quatsomes for enhanced renal targeting: design, optimization and biochemical and nephroprotective assessments.","i":["in-vivo"]}

    作者:
    Sadek Ahmed, Rana M ElBishbishy, Mohamed A Sadek, Osama Saher
    日期:
    2026-01-01

    The kidney plays a critical role in metabolite excretion, fluid regulation, and homeostasis, yet remains highly vulnerable to structural and functional disorders. Kidney diseases represent a major glo…

  5. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    5. Drug-related problems and their predictors in pediatric community-acquired infections: the role of pharmacist-led interventions in Pakistan.

    作者:
    Sana Ali, Ale Zehra, Fakhsheena Anjum, Syed Shaukat Ali Muttaqi Shah, Falak Abro, Sadia Shakeel, Muhammad Ali
    日期:
    2026-01-01

    Drug-Related Problems (DRPs) are a leading cause of preventable harm to hospitalized children, yet the data from low- and middle-income countries (LMICs) are limited. This study aimed to determine the…

  6. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    6. The cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight.

    作者:
    Esraa M Mosalam, Mahmoud S Abdallah, Ahmed R Gardouh, Eman Hamza, Mostafa M Bahaa, Mahmoud Nazih, Reham A Al-Dhelaan, Noha Kamal
    日期:
    2026-01-01

    The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified and studied in the regulation of glycogen synthesis. In some cases, suppression of GSK-3 activity by phosphoryla…

  7. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    7. Quality by design in public healthcare: a rapid development framework for future pandemics.

    作者:
    Niranjan Panda, Madhusudan Maity, Vijay Kotra, Bikash Ranjan Jena, Debashish Ghose, Gouri Sankar Jena
    日期:
    2026-01-01

    The growing number of pandemics and emergencies traversing the world in recent decades has illustrated the vulnerability of the conventional pharmaceutical development process and the necessity of an …

  8. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    8. Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance.

    作者:
    Gatadi Srikanth, Niggula Praveen Kumar, Bhima Sridevi, Padma Bhavani Borra, Parul Thapar, Aabid Wani
    日期:
    2026-01-01

    Antimicrobial resistance (AMR) is a globally accelerating issue threatening the efficacy of existing treatments. Repurposing approved drugs for the development of new antimicrobial agents reduces the …

  9. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    9. Dissolution-permeation approach for biopharmaceutical evaluation: a feasibility study using naproxen.

    作者:
    Andrejs Sitovs, Katarina Gurkina, Liga Petersone, Valentyn Mohylyuk
    日期:
    2026-01-01

    Dissolution and/or release profile alone are insufficient to predict the absorption of poorly soluble drugs. Thus, permeation test becomes a critical component for biopharmaceutical assessment. Curren…

  10. JCR分区: Q1 CAS分区: B4 影响因子: 5.5

    10. Practical considerations for managing patients being treated with topical roflumilast.

    10. 管理使用局部罗氟司特治疗的患者的实际考虑
    作者:
    Sameh Hanna, Ahmad Chehade, Christina Han, Susan Poelman, Ravina Sanghera, Carolyn Whiskin, Aaron Sihota
    日期:
    2026-01-01

    Topical roflumilast, available in 0.3% cream, 0.15% cream, and 0.3% foam formulations, is a novel, highly potent phosphodiesterase-4 (PDE4) inhibitor that was recently approved in Canada for the treat…

在 JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊